Editing Medusa Pharmaceuticals
The edit can be undone. Please check the comparison below to verify that this is what you want to do, and then publish the changes below to finish undoing the edit.
Latest revision | Your text | ||
Line 3: | Line 3: | ||
Reinvigorating antibiotics by repurposing approved drugs to overcome AMR | Reinvigorating antibiotics by repurposing approved drugs to overcome AMR | ||
'''About Medusa Pharmaceuticals:''' | |||
Medusa Pharmaceuticals is an Imperial College London spin-out based on a serendipitous discovery: synergy between an aminoglycoside antibiotic and an alkylating agent, able to overcome antimicrobial resistance, treating lethal infections. | Medusa Pharmaceuticals is an Imperial College London spin-out based on a serendipitous discovery: synergy between an aminoglycoside antibiotic and an alkylating agent, able to overcome antimicrobial resistance, treating lethal infections. | ||
Line 9: | Line 10: | ||
Our strategy repurposes approved drugs, leveraging decades of R&D, overcoming the cost and regulatory hurdles associated with bringing entirely new antibiotics to market. | Our strategy repurposes approved drugs, leveraging decades of R&D, overcoming the cost and regulatory hurdles associated with bringing entirely new antibiotics to market. | ||
'''Medusa Pharmaceuticals’ vision:''' | |||
Combat AMR to treat the untreatable, saving lives all around the world. | Combat AMR to treat the untreatable, saving lives all around the world. | ||
'''Status on current round:''' | |||
Seeking to raise £500k for a 2-year runway enabling a postdoctoral researcher to conduct fundamental early research in Dr Peter Sarkies’ Imperial College lab. | Seeking to raise £500k for a 2-year runway enabling a postdoctoral researcher to conduct fundamental early research in Dr Peter Sarkies’ Imperial College lab. | ||
==Investment Interview | ==Investment Interview== | ||
'''Explain what your venture does.''' | '''Explain what your venture does.''' | ||
Line 71: | Line 76: | ||
We have incorporated the Company (Medusa Pharmaceuticals) and have been granted an exclusive license to the Patent by Imperial, enabling us to begin fundraising and developing the technology and Company. | We have incorporated the Company (Medusa Pharmaceuticals) and have been granted an exclusive license to the Patent by Imperial, enabling us to begin fundraising and developing the technology and Company. | ||
[[Category:Thesis]] | [[Category:Thesis]] | ||
[[Category:Equities]] | [[Category:Equities]] | ||
__INDEX__ | __INDEX__ |